STAT+ Conversation: Selling Cellarity – STAT
Editor’s be aware: A recording of the dialog is embedded beneath.
Every week, STAT+ subscribers get entry to unique conversations with biotech, pharma, and well being tech leaders. This week, STAT basic task reporter and affiliate editorial director of occasions Nicholas St. Fleur sits down with Fabrice Chouraqui, CEO of Cellarity and CEO-partner of Flagship Pioneering. They are going to be discussing how the brand new Flagship agency Cellarity not too long ago raised $123 million to invent medication by understanding mobile networks, what its subsequent steps are, and naturally be taking your questions reside.
Unlock this text by subscribing to STAT+ and revel in your first 30 days free!
GET STARTED
What’s it?
STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, coverage, and life science protection and evaluation.
Our award-winning group covers information on Wall Road, coverage developments in Washington, early science breakthroughs and scientific trial outcomes, and well being care disruption in Silicon Valley and past.
What’s included?
- Every day reporting and evaluation
- Essentially the most complete business protection from a powerhouse group of reporters
- Subscriber-only newsletters
- Every day newsletters to temporary you on a very powerful business information of the day
- STAT+ Conversations
- Weekly alternatives to interact with our reporters and main business consultants in reside video conversations
- Unique business occasions
- Premium entry to subscriber-only networking occasions across the nation
- The most effective reporters within the business
- Essentially the most trusted and well-connected newsroom within the well being care business
- And rather more
- Unique interviews with business leaders, profiles, and premium instruments, like our CRISPR Trackr.
